Welcome to our dedicated page for Northrop Grumman SEC filings (Ticker: NOC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Northrop Grumman Corporation (NOC) SEC filings page on Stock Titan brings together the company’s regulatory disclosures from the U.S. Securities and Exchange Commission, with AI-powered tools to help interpret complex documents. Northrop Grumman is a global aerospace and defense technology company, and its filings provide structured insight into its financial performance, capital structure, governance, and key agreements.
Recent Form 8-K filings illustrate the types of information investors can expect. A July 22, 2025 Form 8-K reports that Northrop Grumman issued an earnings release for the quarter ended June 30, 2025, while an October 21, 2025 Form 8-K notes the release of financial results for the quarter ended September 30, 2025. These current reports reference earnings releases furnished as exhibits, which complement the company’s quarterly reports on Form 10-Q and annual reports on Form 10-K that are also accessible through EDGAR.
Another Form 8-K dated September 2, 2025 describes a material definitive agreement: a five-year senior unsecured revolving credit facility intended to support the company’s commercial paper program and other general corporate purposes. The filing outlines key covenants, including a maximum consolidated debt-to-capitalization ratio and customary events of default. A November 6, 2025 Form 8-K details a chief financial officer transition and related compensation decisions approved by the Compensation and Human Capital Committee.
On this page, Stock Titan surfaces such filings in real time and applies AI-powered summaries to explain the significance of documents like 10-K annual reports, 10-Q quarterly reports, and 8-K current reports. Users can also review disclosures related to material agreements and leadership changes, and locate information that may be relevant to insider transactions reported on Form 4. The goal is to make Northrop Grumman’s regulatory record easier to navigate by highlighting key sections and translating technical language into more accessible explanations.
Northrop Grumman executive Benjamin R. Davies reported multiple equity compensation transactions. On February 11, 2026, he was granted 4,710.32 Restricted Performance Stock Rights and 1,701 Restricted Stock Rights, each representing a contingent right to receive an equal number of common shares or, at the company’s election, cash or a mix of stock and cash.
On the same date, 3,158.32 Restricted Performance Stock Rights were exercised, delivering an equal number of common shares at an exercise price of $0. Of those shares, 1,214 common shares were disposed of at $678.83 per share to satisfy tax obligations, leaving 2,189.04 common shares held directly after the reported transactions, plus a small indirect position held in the Northrop Grumman Savings Plan.
Northrop Grumman’s CVP and President of Space Systems, Robert J. Fleming, reported several equity compensation transactions on February 11, 2026. He received grants of 3,982.16 Restricted Performance Stock Rights (RPSRs) and 1,701 Restricted Stock Rights (RSRs), each representing contingent rights to receive an equal number of common shares or cash.
Fleming also exercised 913.16 RPSRs, which converted into the same number of common shares at an exercise price of $0, increasing his directly owned common stock to 2,740.03 shares. To cover tax obligations related to this equity activity, 300 common shares were disposed of at $678.83 per share through a tax-withholding transaction, leaving him with 2,440.03 common shares held directly.
Northrop Grumman executive Roshan S. Roeder, CVP & President of Mission Systems, reported multiple equity compensation transactions dated February 11, 2026. Roeder acquired 5,786.48 Restricted Performance Stock Rights (RPSRs) and 1,701 Restricted Stock Rights (RSRs), both at an exercise price of $0 per right, as part of long-term incentive plans.
On the same date, 6,476.48 RPSRs were exercised into the same number of common shares at $0, increasing direct common stock holdings to 6,880.39 shares before withholding. To cover tax obligations, 2,968 common shares were disposed of at $678.83 per share, leaving 3,912.39 common shares held directly after the transactions, plus 115.5111 shares held indirectly in the Northrop Grumman Savings Plan as of February 11, 2026.
Northrop Grumman insider plans to sell restricted stock that recently vested. A holder has filed a Form 144 notice to sell up to 784 shares of common stock through Fidelity Brokerage Services on the NYSE, with an aggregate market value of $550,410.63.
The shares were acquired as compensation through restricted stock vesting, including 203 shares on 02/13/2023 and 581 shares on 02/11/2026. The issuer had 141,921,621 common shares outstanding at the time referenced, providing context for the planned sale size.
Northrop Grumman (NOC) reported an insider sale by Chair, CEO and President Kathy J. Warden on February 6, 2026. She sold a total of 20,000 shares of common stock in multiple transactions at weighted average prices ranging from $705.84 to $711.14, with individual trade price ranges between $705.56 and $711.40. Following these sales, she directly owned 171,602.4 shares of Northrop Grumman common stock.
An insider has filed a notice to sell 20,000 shares of common stock, to be executed through Fidelity Brokerage Services LLC on the NYSE around February 6, 2026. The filing lists an aggregate market value of 14,176,423.20 for these shares, with 141,921,621 shares of the class outstanding.
The shares to be sold were acquired through restricted stock vesting from the issuer on February 13, 2022, February 15, 2022, and February 14, 2024 as compensation. Over the prior three months, the same seller disposed of 7,000 shares of common stock on January 5, 2026 for 4,200,000.00 and a further 3,000 shares on January 6, 2026 for 1,845,000.00.
Northrop Grumman director Mark A. Welsh III reported open-market sales of 95 shares of common stock on February 2, 2026. The sales were made in multiple small trades under a Rule 10b5-1 trading plan adopted on August 23, 2025.
The reported transactions occurred at weighted average prices ranging from $676.14 to $689.31 per share. After these sales, Welsh directly beneficially owns 4,203 shares of Northrop Grumman common stock.
Northrop Grumman Corporation outlines its 2025 business, scale and risks as a leading global aerospace and defense technology company focused on U.S. and international security customers, especially the U.S. Department of War and intelligence community.
The company operates through four segments — Aeronautics Systems, Defense Systems, Mission Systems and Space Systems — covering aircraft, missiles, space systems, sensors, cyber and command-and-control solutions, with a mix of open and restricted programs.
In 2025, total sales were $ in millions: U.S. Government $35,183, International $5,990, Other $781, Total $41,954, split about evenly between cost-type and fixed-price contracts, and U.S. government sales represented 84% of revenue. Backlog reached $95.7 billion, up from $91.5 billion a year earlier, indicating multi‑year revenue visibility.
As of June 30, 2025, non‑affiliate market value of common stock was about $71.5 billion, and as of January 22, 2026 there were 141,921,621 shares outstanding. The company employed about 95,000 people at year‑end 2025 after hiring roughly 7,500 in 2025, and discusses extensive risk factors spanning dependence on U.S. defense budgets, cost estimation and contract risk, macroeconomic and supply chain pressures, cybersecurity, environmental obligations and evolving regulations.
Northrop Grumman Corporation filed a current report to note that it has released its financial results for the fourth quarter and full year ended December 31, 2025. On January 27, 2026, the company issued an earnings release titled “Northrop Grumman Reports Fourth Quarter and Full-Year 2025 Financial Results,” which is included as Exhibit 99 to this report. The filing identifies this earnings release as furnished information on results of operations and financial condition, rather than detailed financial statements within the report itself.
Northrop Grumman Corporation’s Chief Financial Officer, John Greene, filed an initial ownership report stating that he beneficially owns no company securities. The Form 3 shows that as of 01/07/2026, he held 0 shares of common stock directly and reported no derivative securities such as options or warrants. A remark reiterates that no securities are beneficially owned, and a power of attorney is noted as an exhibit, indicating that the filing was submitted on his behalf by an attorney-in-fact.